Form D — ImmunoGenesis, Inc.
0002018057-25-000001 · filed Jan 15, 2025
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $24,999,999
- Total sold
- $5,749,998
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- ImmunoGenesis, Inc.
- CIK
- 2018057
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 263 North Main St., Apt 417
Doylestown, PA 18901 - Phone
- 3467720336
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Jennifer Barlow · Executive OfficerDoylestown, PA Find on LinkedIn ↗
-
Ted Koutouzis · DirectorDoylestown, PA Find on LinkedIn ↗
-
Robert B. Stein · DirectorDoylestown, PA Find on LinkedIn ↗
-
Clifford Stocks · DirectorDoylestown, PA Find on LinkedIn ↗
-
Michael A. Curran · DirectorDoylestown, PA Find on LinkedIn ↗
-
Thomas Barton · DirectorDoylestown, PA Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗